Literature DB >> 11691511

Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.

M Hayashi1, T Tsutamoto, A Wada, K Maeda, N Mabuchi, T Tsutsui, T Matsui, M Fujii, T Matsumoto, T Yamamoto, H Horie, M Ohnishi, M Kinoshita.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate whether plasma aldosterone (ALD) is extracted or produced through the heart in patients with acute myocardial infarction (AMI) and to determine the relationship between transcardiac extraction of plasma ALD and left ventricular (LV) remodeling.
BACKGROUND: Although we demonstrated that circulating ALD was extracted through the failing heart and that transcardiac extraction of ALD correlated with LV end-diastolic volume index (LVEDVI) in patients with congestive heart failure, the existence and increase of ALD synthase in the hearts of infarct rats were reported, suggesting cardiac production of ALD in patients with AMI.
METHODS: We measured plasma ALD in the aortic root (Ao) and coronary sinus (CS) in 57 consecutive patients who received successful revascularization and enalapril, with first AMI at acute phase and after one month. We also measured plasma procollagen type III aminoterminal peptide (PIIINP) in the CS.
RESULTS: Plasma ALD was significantly lower in the CS than it was in the Ao at the acute phase (84.7 +/- 6.3 pg/ml vs. 105.5 +/- 8.0 pg/ml, p < 0.0001). Significant positive correlations exist between the transcardiac gradient of ALD at the acute phase and the LVEDVI at one month. Moreover, the transcardiac gradient of plasma ALD at the acute phase has a significant correlation with plasma PIIINP, a biochemical marker of fibrosis, after one month. Stepwise multivariate analysis showed that transcardiac extraction of plasma ALD at the acute phase had an independent and significant positive relationship with a large LVEDVI after one month.
CONCLUSIONS: These results indicate that plasma ALD is extracted through the heart in patients with AMI at the acute phase and that the extracted ALD plays an important role in modulating post-infarct LV remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691511     DOI: 10.1016/s0735-1097(01)01539-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

Review 1.  A reappraisal of loop diuretic choice in heart failure patients.

Authors:  Jonathan Buggey; Robert J Mentz; Bertram Pitt; Eric L Eisenstein; Kevin J Anstrom; Eric J Velazquez; Christopher M O'Connor
Journal:  Am Heart J       Date:  2015-01-06       Impact factor: 4.749

Review 2.  Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction.

Authors:  Keyur B Shah; Stephen S Gottlieb
Journal:  Curr Heart Fail Rep       Date:  2004-12

3.  Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.

Authors:  Matthew Fomonyuy Yuyun; Sandeep K Jutla; Paulene A Quinn; Leong L Ng
Journal:  Heart Asia       Date:  2012-08-24

Review 4.  Novel pharmacotherapies to abrogate postinfarction ventricular remodeling.

Authors:  Gerald W Dorn
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

Review 5.  Aldosterone and cardiovascular disease: the heart of the matter.

Authors:  B Julie He; Mark E Anderson
Journal:  Trends Endocrinol Metab       Date:  2012-10-03       Impact factor: 12.015

Review 6.  Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist.

Authors:  Anil Verma; Scott D Solomon
Journal:  Curr Heart Fail Rep       Date:  2007-12

7.  Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community.

Authors:  Thomas J Wang; Martin G Larson; Emelia J Benjamin; Deborah A Siwik; Radwan Safa; Chao-Yu Guo; Diane Corey; Johan Sundstrom; Douglas B Sawyer; Wilson S Colucci; Ramachandran S Vasan
Journal:  Am Heart J       Date:  2007-08       Impact factor: 4.749

8.  Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.

Authors:  Mona Fiuzat; Phillip J Schulte; Michael Felker; Tariq Ahmad; Megan Neely; Kirkwood F Adams; Mark P Donahue; William E Kraus; Ileana L Piña; David J Whellan; Christopher M O'Connor
Journal:  J Card Fail       Date:  2013-12-01       Impact factor: 5.712

9.  Pathological ventricular remodeling: therapies: part 2 of 2.

Authors:  Min Xie; Jana S Burchfield; Joseph A Hill
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

Review 10.  Efficacy of aldosterone receptor antagonism in heart failure: potential mechanisms.

Authors:  Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.